Contact us

Should We Worry About Ileus with Pines and Cobenfy? Reconsidering the Risk

As the psychiatric community continues to explore Cobenfy (xanomeline/trospium chloride) as a novel option in the treatment of schizophrenia, questions have emerged regarding its safety when used in combination with antipsychotics from the “-pine” family—such as clozapine, olanzapine, and quetiapine.

Raising the Bar: Abilify Maintena’s New Dosing Option and the Real-World Cost of Missed Opportunities

Rethinking ADHD Treatment: The Promise of Evening-Dosed Medication

Attention-Deficit/Hyperactivity Disorder (ADHD) affects millions of children, adolescents, and adults across the country. While symptoms like distractibility, impulsivity, and hyperactivity often take center stage, what’s less often talked about is the day-to-day disruption ADHD can cause—for both individuals and their families.